PRECISION IMMUNOLOGY LABORATORY SHARED RESOURCE (PIL) The Precision Immunology Laboratory Shared Resource (PIL) is a highly restructured PCC Shared Resource designed to comprehensively study immune cell phenotype and function. The mission of PIL is to characterize and understand anti-tumor immune responses, determine mechanisms by which immune escape and evasion occur, and predict patient responses to cancer immunotherapy, in support of Perlmutter Cancer Center (PCC) investigators. Under the direction of world-recognized immune monitoring expert Dr. Pratip Chattopadhyay, formerly of the NIH Vaccine Center, PIL offers a wide range of services for immune monitoring, including high quality cell processing and immunoassays for PCC clinical trials, with rigorous quality control and bioinformatics capabilities to interpret the results. PIL also provides a wide range of flow cytometry services (including education) for basic, population and clinical researchers at PCC, and applies cutting-edge technology for high parameter, single cell immune analysis, that provides results that are robust, accessible, and interpretable by researchers and clinicians.
The Specific Aims of PIL are:
Aim 1) To provide high-quality cell processing and immunoassays for PCC clinical trials with vigorous quality control and bioinformatics capabilities;
Aim 2) To provide a wide range of flow cytometry services, including education;
Aim 3) To develop and apply cutting-edge technology for high parameter, single cell immune analysis providing robust results no generally available elsewhere.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016087-38
Application #
9633412
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
2024-02-29
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
38
Fiscal Year
2019
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Burgess, Hannah M; Pourchet, Aldo; Hajdu, Cristina H et al. (2018) Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus. Mol Ther Oncolytics 8:71-81
Wong, Serre-Yu; Coffre, Maryaline; Ramanan, Deepshika et al. (2018) B Cell Defects Observed in Nod2 Knockout Mice Are a Consequence of a Dock2 Mutation Frequently Found in Inbred Strains. J Immunol 201:1442-1451
Handler, Jesse; Cullis, Jane; Avanzi, Antonina et al. (2018) Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-? exposure. Oncogene 37:4334-4342
Diamond, Julie M; Vanpouille-Box, Claire; Spada, Sheila et al. (2018) Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs. Cancer Immunol Res 6:910-920
Fan, Xiaozhou; Peters, Brandilyn A; Jacobs, Eric J et al. (2018) Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome 6:59
Chen, Danqi; Fang, Lei; Mei, Shenglin et al. (2018) Erratum: ""Regulation of Chromatin Assembly and Cell Transformation by Formaldehyde Exposure in Human Cells"". Environ Health Perspect 126:019001
Khodadadi-Jamayran, Alireza; Akgol-Oksuz, Betul; Afanasyeva, Yelena et al. (2018) Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process. Oncotarget 9:12868-12878
Wadghiri, Youssef Z; Hoang, Dung Minh; Leporati, Anita et al. (2018) High-resolution Imaging of Myeloperoxidase Activity Sensors in Human Cerebrovascular Disease. Sci Rep 8:7687
Wang, Shiyang; Liechty, Benjamin; Patel, Seema et al. (2018) Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors. J Neurooncol 138:183-190
Nancy, Patrice; Siewiera, Johan; Rizzuto, Gabrielle et al. (2018) H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. J Clin Invest 128:233-247

Showing the most recent 10 out of 1170 publications